Software Healthcare Sector

Algernon Pharmaceuticals

Market Cap: CA$2.5m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

1933 Industries

Market Cap: CA$2.5m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Diagnamed Holdings

Market Cap: CA$2.4m

Engages in the development and commercialization of AI healthcare solutions.

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

ENDRA Life Sciences

Market Cap: US$1.8m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.

Galera Therapeutics

Market Cap: US$1.8m

A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Medicine Man Technologies

Market Cap: US$1.7m

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.

InVitro International

Market Cap: US$1.7m

Develops test kits for non-animal testing applications in the United States and internationally.

TNF Pharmaceuticals

Market Cap: US$1.7m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

United American Healthcare

Market Cap: US$1.7m

Through its subsidiaries, provides contract manufacturing services to the medical device industry.

Binovi Technologies

Market Cap: CA$2.3m

Engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally.

Kaya Holdings

Market Cap: US$1.6m

A vertically integrated legal cannabis enterprise, engages in the operation of psychedelic treatment clinics, medical and recreational cannabis, and CBD products primarily in the United States.

Helix BioMedix

Market Cap: US$1.6m

Operates as a specialty dermatology and consumer products skin health company in the United States.

Osteopore

Market Cap: AU$2.4m

A regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, the United States, Malaysia, Indonesia, Netherlands, Thailand, Australia, and internationally.

Imagion Biosystems

Market Cap: AU$2.4m

Provides medical imaging technologies using magnetic resonance.

Hempshire Group

Market Cap: CA$2.1m

Engages in the production and distribution of CBD Hemp smokes.

American Green

Market Cap: US$1.5m

Operates as a technology company in the medical cannabis industry in the United States.

MyndTec

Market Cap: CA$2.1m

A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.

RespireRx Pharmaceuticals

Market Cap: US$1.5m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Meridian Holdings

Market Cap: US$1.5m

Through its subsidiaries, provides healthcare management and information system solutions in the United States.

GelStat

Market Cap: US$1.5m

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products.

West Island Brands

Market Cap: CA$2.0m

Engages in the medical marijuana business.

Procyon

Market Cap: US$1.5m

Manufactures and markets wound and skin care products primarily in the United States.

Bio-Path Holdings

Market Cap: US$1.5m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

Restart Life Sciences

Market Cap: CA$2.0m

Through its subsidiaries, operates as a biotechnology company worldwide.

LungLife AI

Market Cap: UK£1.1m

A diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People’s Republic of China.

TILT Holdings

Market Cap: CA$2.0m

Provides various cannabis products and services in the United States, Canada, and internationally.

SOHM

Market Cap: US$1.4m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

CardioComm Solutions

Market Cap: CA$1.9m

Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.

Know Labs

Market Cap: US$1.4m

Focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.

Salarius Pharmaceuticals

Market Cap: US$1.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

Acura Pharmaceuticals

Market Cap: US$1.3m

An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.